Ghrelin in the regulation of body weight and metabolism

Frontiers in Neuroendocrinology

Volumn 31, Issue 1, 2010, Pages 44-60

  Castaneda T R ^a   Tong, J ^b   Datta, R ^c   Culler, M ^c   Tschop M H ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Biomeasure Inc   (United States)

Author keywords

Cachexia; Diabetes; Ghrelin; Growth hormone; Obesity

Indexed keywords

BIM 28163; CAPROMORELIN; CP 464709 18; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE; GSK 894490 A; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HORMONE ANALOG; IBUTAMOREN; L NOX B 11; NEUROPEPTIDE Y; PLACEBO; RC 1139; RC 1291; TZP 101; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANOREXIA NERVOSA; ANXIETY DISORDER; BLOOD BRAIN BARRIER; BODY WEIGHT; CACHEXIA; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; COGNITIVE DEFECT; DOSE RESPONSE; DRUG HALF LIFE; DRUG MECHANISM; ENERGY BALANCE; GASTROINTESTINAL MOTILITY; GLUCOSE HOMEOSTASIS; HEART FAILURE; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; ILEUS; INSULIN RESISTANCE; LEARNING DISORDER; MEMORY; MEMORY DISORDER; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STOMACH PARESIS; TACHYPNEA;

AGOUTI-RELATED PROTEIN; AMINO ACID SEQUENCE; ANIMALS; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; BODY WEIGHT; CACHEXIA; EATING; ENERGY METABOLISM; GASTROINTESTINAL MOTILITY; GHRELIN; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; OBESITY; RECEPTORS, GHRELIN; WEIGHT GAIN;

EID: 72449192299     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2009.10.008     Document Type: Review

References (312)

1. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschop M.H., Gao X.B., and Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116 (2006) 3229-3239
2. Akamizu T., Takaya K., Irako T., Hosoda H., Teramukai S., Matsuyama A., Tada H., Miura K., Shimizu A., Fukushima M., Yokode M., Tanaka K., and Kangawa K. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur. J. Endocrinol. 150 (2004) 447-455
3. Akamizu T., Shinomiya T., Irako T., Fukunaga M., Nakai Y., Nakai Y., and Kangawa K. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J. Clin. Endocrinol. Metab. 90 (2005) 6-9
4. Akamizu T., Murayama T., Teramukai S., Miura K., Bando I., Irako T., Iwakura H., Ariyasu H., Hosoda H., Tada H., Matsuyama A., Kojima S., Wada T., Wakatsuki Y., Matsubayashi K., Kawakita T., Shimizu A., Fukushima M., Yokode M., and Kangawa K. Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure. J. Endocrinol. 188 (2006) 333-344
5. Andreis P.G., Malendowicz L.K., Trejter M., Neri G., Spinazzi R., Rossi G.P., and Nussdorfer G.G. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett. 536 (2003) 173-179
6. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., Tschop M.H., Shanabrough M., Cline G., Shulman G.I., Coppola A., Gao X.B., Horvath T.L., and Diano S. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454 (2008) 846-851
7. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., and Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86 (2001) 4753-4758
8. Ariyasu H., Takaya K., Iwakura H., Hosoda H., Akamizu T., Arai Y., Kangawa K., and Nakao K. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 146 (2005) 355-364
9. Arnold M., Mura A., Langhans W., and Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J. Neurosci. 26 (2006) 11052-11060
10. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., Casanueva F.F., Deghenghi R., Camanni F., and Ghigo E. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 86 (2001) 1169-1174
11. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., Katsuura G., Makino S., Fujino M.A., and Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74 (2001) 143-147
12. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., and Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
13. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., and Kasuga M. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52 (2003) 947-952
14. Atcha Z., Chen W.S., Ong A.B., Wong F.K., Neo A., Browne E.R., Witherington J., and Pemberton D.J. Cognitive enhancing effects of ghrelin receptor agonists. Psychopharmacology (Berlin) (2009)
15. Bagnasco M., Tulipano G., Melis M.R., Argiolas A., Cocchi D., and Muller E.E. Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul. Pept. 111 (2003) 161-167
16. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., and Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159 (2002) 1029-1037
17. Banks W.A., Tschop M., Robinson S.M., and Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 302 (2002) 822-827
18. Banks W.A., Burney B.O., and Robinson S.M. Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides 29 (2008) 2061-2065
19. Barazzoni R., Bosutti A., Stebel M., Cattin M.R., Roder E., Visintin L., Cattin L., Biolo G., Zanetti M., and Guarnieri G. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E228-E235
20. Bassil A.K., Dass N.B., and Sanger G.J. The prokinetic-like activity of ghrelin in rat isolated stomach is mediated via cholinergic and tachykininergic motor neurones. Eur. J. Pharmacol. 544 (2006) 146-152
21. Bays H., and Dujovne C. Anti-obesity drug development. Expert. Opin. Invest. Drug. 11 (2002) 1189-1204
22. Beaumont N.J., Skinner V.O., Tan T.M., Ramesh B.S., Byrne D.J., MacColl G.S., Keen J.N., Bouloux P.M., Mikhailidis D.P., Bruckdorfer K.R., Vanderpump M.P., and Srai K.S. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J. Biol. Chem. 278 (2003) 8877-8880
23. Beck B., Musse N., and Stricker-Krongrad A. Ghrelin, macronutrient intake and dietary preferences in long-evans rats. Biochem. Biophys. Res. Commun. 292 (2002) 1031-1035
24. Bedendi I., Alloatti G., Marcantoni A., Malan D., Catapano F., Ghe C., Deghenghi R., Ghigo E., and Muccioli G. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur. J. Pharmacol. 476 (2003) 87-95
25. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., Warren V.A., Howard A.D., Van Der Ploeg L.H., and Heck J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43 (2000) 4370-4376
26. Bellone S., Rapa A., Vivenza D., Castellino N., Petri A., Bellone J., Me E., Broglio F., Prodam F., Ghigo E., and Bona G. Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J. Endocrinol. Invest. 25 (2002) RC13-RC15
27. Bertoli S., Magni P., Krogh V., Ruscica M., Dozio E., Testolin G., and Battezzati A. Is ghrelin a signal of decreased fat-free mass in elderly subjects?. Eur. J. Endocrinol. 155 (2006) 321-330
28. Biebermann H., Castaneda T.R., van Landeghem F., von Deimling A., Escher F., Brabant G., Hebebrand J., Hinney A., Tschop M.H., Gruters A., and Krude H. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3 (2006) 141-146
29. Binn M., Albert C., Gougeon A., Maerki H., Coulie B., Lemoyne M., Rabasa Lhoret R., Tomasetto C., and Poitras P. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 27 (2006) 1603-1606
30. Bluet-Pajot M.T., Epelbaum J., Gourdji D., Hammond C., and Kordon C. Hypothalamic and hypophyseal regulation of growth hormone secretion. Cell. Mol. Neurobiol. 18 (1998) 101-123
31. Bodart V., Febbraio M., Demers A., McNicoll N., Pohankova P., Perreault A., Sejlitz T., Escher E., Silverstein R.L., Lamontagne D., and Ong H. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ. Res. 90 (2002) 844-849
32. Bowen J., Noakes M., Trenerry C., and Clifton P.M. Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men. J. Clin. Endocrinol. Metab. 91 (2006) 1477-1483
33. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., van der Lely A.J., Deghenghi R., and Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 86 (2001) 5083-5086
34. Broglio F., Koetsveld Pv P., Benso A., Gottero C., Prodam F., Papotti M., Muccioli G., Gauna C., Hofland L., Deghenghi R., Arvat E., Van Der Lely A.J., and Ghigo E. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J. Clin. Endocrinol. Metab. 87 (2002) 4829-4832
35. Broglio F., Gianotti L., Destefanis S., Fassino S., Abbate Daga G., Mondelli V., Lanfranco F., Gottero C., Gauna C., Hofland L., Van der Lely A.J., and Ghigo E. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin. Endocrinol. (Oxford) 60 (2004) 592-599
36. Broglio F., Gottero C., Van Koetsveld P., Prodam F., Destefanis S., Benso A., Gauna C., Hofland L., Arvat E., van der Lely A.J., and Ghigo E. Acetylcholine regulates ghrelin secretion in humans. J. Clin. Endocrinol. Metab. 89 (2004) 2429-2433
37. Brunetti L., Recinella L., Orlando G., Michelotto B., Di Nisio C., and Vacca M. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur. J. Pharmacol. 454 (2002) 189-192
38. Bunt J.C., Salbe A.D., Tschop M.H., DelParigi A., Daychild P., and Tataranni P.A. Cross-sectional and prospective relationships of fasting plasma ghrelin concentrations with anthropometric measures in Pima Indian children. J. Clin. Endocrinol. Metab. 88 (2003) 3756-3761
39. Capalbo D., Lo Vecchio A., Farina V., Spinelli L., Palladino A., Tiano C., Lettiero T., Lombardi G., Colao A., and Salerno M. Subtle alterations of cardiac performance in children with Growth Hormone deficiency: results of a two years prospective, case-control study. J. Clin. Endocrinol. Metab. (2009)
40. Cappiello V., Ronchi C., Morpurgo P.S., Epaminonda P., Arosio M., Beck-Peccoz P., and Spada A. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur. J. Endocrinol. 147 (2002) 189-194
41. Carlini V.P., Monzon M.E., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., and de Barioglio S.R. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem. Biophys. Res. Commun. 299 (2002) 739-743
42. Carlini V.P., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., and de Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem. Biophys. Res. Commun. 313 (2004) 635-641
43. Carlini V.P., Schioth H.B., and Debarioglio S.R. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem. Biophys. Res. Commun. 352 (2007) 907-912
44. Carlini V.P., Martini A.C., Schioth H.B., Ruiz R.D., Fiol de Cuneo M., and de Barioglio S.R. Decreased memory for novel object recognition in chronically food-restricted mice is reversed by acute ghrelin administration. Neuroscience (2008) 88
45. Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., and Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 86 (2001) 1738-1745
46. Cassoni P., Ghe C., Marrocco T., Tarabra E., Allia E., Catapano F., Deghenghi R., Ghigo E., Papotti M., and Muccioli G. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur. J. Endocrinol. 150 (2004) 173-184
47. Chapman I.M., Bach M.A., Van Cauter E., Farmer M., Krupa D., Taylor A.M., Schilling L.M., Cole K.Y., Skiles E.H., Pezzoli S.S., Hartman M.L., Veldhuis J.D., Gormley G.J., and Thorner M.O. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J. Clin. Endocrinol. Metab. 81 (1996) 4249-4257
48. Chapman I.M., Pescovitz O.H., Murphy G., Treep T., Cerchio K.A., Krupa D., Gertz B., Polvino W.J., Skiles E.H., Pezzoli S.S., and Thorner M.O. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults. J. Clin. Endocrinol. Metab. 82 (1997) 3455-3463
49. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., Chomarat P., Coge F., Nosjean O., Rodriguez M., Galizzi J.P., Boutin J.A., Vaudry H., and Llorens-Cortes C. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 (2007) 766 (author reply 766)
50. Chen C., Wu D., and Clarke I.J. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J. Endocrinol. 148 (1996) 381-386
51. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., Shen Z., Marsh D.J., Feighner S.D., Guan X.M., Ye Z., Nargund R.P., Smith R.G., Van der Ploeg L.H., Howard A.D., MacNeil D.J., and Qian S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145 (2004) 2607-2612
52. Choi K., Roh S.G., Hong Y.H., Shrestha Y.B., Hishikawa D., Chen C., Kojima M., Kangawa K., and Sasaki S. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144 (2003) 754-759
53. Colombo M., Gregersen S., Xiao J., and Hermansen K. Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas 27 (2003) 161-166
54. Cone R.D., Cowley M.A., Butler A.A., Fan W., Marks D.L., and Low M.J. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25 Suppl. 5 (2001) S63-S67
55. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl. J. Med. 334 (1996) 292-295
56. Corpas E., Harman S.M., and Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 14 (1993) 20-39
57. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., and Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 (2003) 649-661
58. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol. Behav. 89 (2006) 71-84
59. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., and Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
60. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., and Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New Engl. J. Med. 346 (2002) 1623-1630
61. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., and Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E297-E304
62. Cuntz U., Fruhauf E., Wawarta R., Tschop M., Folwaczny C., Riepl R., Lehnert P., Fichter M., and Otto B. A role for the novel weight-regulating hormone ghrelin in anorexia nervosa. Am. Clin. Lab. 21 (2002) 22-23
63. Damjanovic S.S., Lalic N.M., Pesko P.M., Petakov M.S., Jotic A., Miljic D., Lalic K.S., Lukic L., Djurovic M., and Djukic V.B. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients. J. Clin. Endocrinol. Metab. 91 (2006) 2574-2581
64. Dass N.B., Munonyara M., Bassil A.K., Hervieu G.J., Osbourne S., Corcoran S., Morgan M., and Sanger G.J. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 120 (2003) 443-453
65. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., and Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 (2002) 1120-1128
66. De Vriese C., Gregoire F., De Neef P., Robberecht P., and Delporte C. Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology 146 (2005) 1514-1522
67. De Vriese C., Hacquebard M., Gregoire F., Carpentier Y., and Delporte C. Ghrelin interacts with human plasma lipoproteins. Endocrinology 148 (2007) 2355-2362
68. De Winter B.Y., De Man J.G., Seerden T.C., Depoortere I., Herman A.G., Peeters T.L., and Pelckmans P.A. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol. Motility 16 (2004) 439-446
69. DelParigi A., Tschop M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., Bunt J.C., and Tataranni P.A. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 5461-5464
70. Demange L., Boeglin D., Moulin A., Mousseaux D., Ryan J., Berge G., Gagne D., Heitz A., Perrissoud D., Locatelli V., Torsello A., Galleyrand J.C., Fehrentz J.A., and Martinez J. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1. J. Med. Chem. 50 (2007) 1939-1957
71. Dezaki K., Hosoda H., Kakei M., Hashiguchi S., Watanabe M., Kangawa K., and Yada T. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 53 (2004) 3142-3151
72. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., Hosoda H., Kangawa K., and Yada T. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55 (2006) 3486-3493
73. Diano S., Farr S.A., Benoit S.C., McNay E.C., da Silva I., Horvath B., Gaskin F.S., Nonaka N., Jaeger L.B., Banks W.A., Morley J.E., Pinto S., Sherwin R.S., Xu L., Yamada K.A., Sleeman M.W., Tschop M.H., and Horvath T.L. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9 (2006) 381-388
74. Drazen D.L., Vahl T.P., D'Alessio D.A., Seeley R.J., and Woods S.C. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 147 (2006) 23-30
75. Eden Engstrom B., Burman P., Holdstock C., and Karlsson F.A. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J. Clin. Endocrinol. Metab. 88 (2003) 5193-5198
76. Edholm T., Levin F., Hellstrom P.M., and Schmidt P.T. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul. Pept. 121 (2004) 25-30
77. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., and Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur. J. Endocrinol. 146 (2002) 241-244
78. Esler W.P., Rudolph J., Claus T.H., Tang W., Barucci N., Brown S.E., Bullock W., Daly M., Decarr L., Li Y., Milardo L., Molstad D., Zhu J., Gardell S.J., Livingston J.N., and Sweet L.J. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148 (2007) 5175-5185
79. Espelund U., Hansen T.K., Orskov H., and Frystyk J. Assessment of ghrelin. APMIS Suppl. (2003) 140-145
80. Everitt B.J., Hokfelt T., Terenius L., Tatemoto K., Mutt V., and Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11 (1984) 443-462
81. Faraj M., Havel P.J., Phelis S., Blank D., Sniderman A.D., and Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab. 88 (2003) 1594-1602
82. Faulconbridge L.F., Cummings D.E., Kaplan J.M., and Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes 52 (2003) 2260-2265
83. Fick L.J., Cai F., and Belsham D.D. Hypothalamic preproghrelin gene expression is repressed by insulin via both PI3-K/Akt and ERK1/2 MAPK pathways in immortalized, hypothalamic neurons. Neuroendocrinology (2008)
84. Filigheddu N., Gnocchi V.F., Coscia M., Cappelli M., Porporato P.E., Taulli R., Traini S., Baldanzi G., Chianale F., Cutrupi S., Arnoletti E., Ghe C., Fubini A., Surico N., Sinigaglia F., Ponzetto C., Muccioli G., Crepaldi T., and Graziani A. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol. Biol. Cell 18 (2007) 986-994
85. Foster-Schubert K.E., Overduin J., Prudom C.E., Liu J., Callahan H.S., Gaylinn B.D., Thorner M.O., and Cummings D.E. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J. Clin. Endocrinol. Metab. 93 (2008) 1971-1979
86. Fujino K., Inui A., Asakawa A., Kihara N., Fujimura M., and Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J. Physiol. 550 (2003) 227-240
87. Fukuda H., Mizuta Y., Isomoto H., Takeshima F., Ohnita K., Ohba K., Omagari K., Taniyama K., and Kohno S. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand. J. Gastroenterol. 39 (2004) 1209-1214
88. Gamaro G.D., Manoli L.P., Torres I.L., Silveira R., and Dalmaz C. Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem. Int. 42 (2003) 107-114
89. Garcia J.M., and Polvino W.J. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 12 (2007) 594-600
90. Garcia J.M., and Polvino W.J. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm IGF Res 19 (2009) 267-273
91. Gauna C., Meyler F.M., Janssen J.A., Delhanty P.J., Abribat T., van Koetsveld P., Hofland L.J., Broglio F., Ghigo E., and van der Lely A.J. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J. Clin. Endocrinol. Metab. 89 (2004) 5035-5042
92. Gaytan F., Barreiro M.L., Chopin L.K., Herington A.C., Morales C., Pinilla L., Casanueva F.F., Aguilar E., Dieguez C., and Tena-Sempere M. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J. Clin. Endocrinol. Metab. 88 (2003) 879-887
93. Ghe C., Cassoni P., Catapano F., Marrocco T., Deghenghi R., Ghigo E., Muccioli G., and Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 143 (2002) 484-491
94. Gibney J., Wallace J.D., Spinks T., Schnorr L., Ranicar A., Cuneo R.C., Lockhart S., Burnand K.G., Salomon F., Sonksen P.H., and Russell-Jones D. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J. Clin. Endocrinol. Metab. 84 (1999) 2596-2602
95. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., and Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87 (2002) 2988
96. Gourcerol G., Coskun T., Craft L.S., Mayer J.P., Heiman M.L., Wang L., Million M., St-Pierre D.H., and Tache Y. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15 (2007) 2643-2652
97. Greenman Y., Golani N., Gilad S., Yaron M., Limor R., and Stern N. Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin. Endocrinol. (Oxford) 60 (2004) 382-388
98. Gropp E., Shanabrough M., Borok E., Xu A.W., Janoschek R., Buch T., Plum L., Balthasar N., Hampel B., Waisman A., Barsh G.S., Horvath T.L., and Bruning J.C. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8 (2005) 1289-1291
99. Grove K.L., and Cowley M.A. Is ghrelin a signal for the development of metabolic systems?. J. Clin. Invest. 115 (2005) 3393-3397
100. Grundy S.M. Multifactorial causation of obesity: implications for prevention. Am. J. Clin. Nutr. 67 (1998) 563S-572S
101. Gualillo O., Caminos J., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., Dieguez C., and Casanueva F. Ghrelin, a novel placental-derived hormone. Endocrinology 142 (2001) 788-794
102. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., and Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48 (1997) 23-29
103. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., Witcher D.R., Luo S., Onyia J.E., and Hale J.E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. USA 105 (2008) 6320-6325
104. Hahn T.M., Breininger J.F., Baskin D.G., and Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1 (1998) 271-272
105. Halem H.A., Taylor J.E., Dong J.Z., Shen Y., Datta R., Abizaid A., Diano S., Horvath T., Zizzari P., Bluet-Pajot M.T., Epelbaum J., and Culler M.D. Novel analogs of ghrelin: physiological and clinical implications. Eur. J. Endocrinol. 151 Suppl. 1 (2004) S71-S75
106. Halem H.A., Taylor J.E., Dong J.Z., Shen Y., Datta R., Abizaid A., Diano S., Horvath T.L., and Culler M.D. A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain. Neuroendocrinology 81 (2005) 339-349
107. Hanada T., Toshinai K., Kajimura N., Nara-Ashizawa N., Tsukada T., Hayashi Y., Osuye K., Kangawa K., Matsukura S., and Nakazato M. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem. Biophys. Res. Commun. 301 (2003) 275-279
108. Hanada T., Toshinai K., Date Y., Kajimura N., Tsukada T., Hayashi Y., Kangawa K., and Nakazato M. Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells. Metabolism 53 (2004) 84-88
109. Harrold J.A., Dovey T., Cai X.J., Halford J.C., and Pinkney J. Autoradiographic analysis of ghrelin receptors in the rat hypothalamus. Brain Res. 1196 (2008) 59-64
110. Hattori N., Saito T., Yagyu T., Jiang B.H., Kitagawa K., and Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 86 (2001) 4284-4291
111. Heath R.B., Jones R., Frayn K.N., and Robertson M.D. Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J. Endocrinol. 180 (2004) 273-281
112. Heijboer A.C., van den Hoek A.M., Parlevliet E.T., Havekes L.M., Romijn J.A., Pijl H., and Corssmit E.P. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 49 (2006) 732-738
113. Helmling S., Maasch C., Eulberg D., Buchner K., Schroder W., Lange C., Vonhoff S., Wlotzka B., Tschop M.H., Rosewicz S., and Klussmann S. Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer. Proc. Natl. Acad. Sci. USA 101 (2004) 13174-13179
114. Hewson A.K., and Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J. Neuroendocrinol. 12 (2000) 1047-1049
115. Hill J.O., and Peters J.C. Environmental contributions to the obesity epidemic. Science 280 (1998) 1371-1374
116. Hinney A., Hoch A., Geller F., Schafer H., Siegfried W., Goldschmidt H., Remschmidt H., and Hebebrand J. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J. Clin. Endocrinol. Metab. 87 (2002) 2716
117. Holdstock C., Engstrom B.E., Ohrvall M., Lind L., Sundbom M., and Karlsson F.A. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J. Clin. Endocrinol. Metab. 88 (2003) 3177-3183
118. Holliday N.D., Holst B., Rodionova E.A., Schwartz T.W., and Cox H.M. Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol. Endocrinol. 21 (2007) 3100-3112
119. Holst B., and Schwartz T.W. Ghrelin receptor mutations - too little height and too much hunger. J. Clin. Invest. 116 (2006) 637-641
120. Holst B., Cygankiewicz A., Jensen T.H., Ankersen M., and Schwartz T.W. High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol. Endocrinol. 17 (2003) 2201-2210
121. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., and Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 279 (2004) 53806-53817
122. Holst B., Brandt E., Bach A., Heding A., and Schwartz T.W. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Mol. Endocrinol. 19 (2005) 2400-2411
123. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., Storjohann L., Stidsen C.E., Jones R., Beck-Sickinger A.G., and Schwartz T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148 (2007) 13-20
124. Holst B., Mokrosinski J., Lang M., Brandt E., Nygaard R., Frimurer T.M., Beck-Sickinger A.G., and Schwartz T.W. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J. Biol. Chem. 282 (2007) 15799-15811
125. Holst B., Frimurer T.M., Mokrosinski J., Halkjaer T., Cullberg K.B., Underwood C.R., and Schwartz T.W. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor. Mol. Pharmacol. 75 (2009) 44-59
126. Hosoda H., and Kangawa K. Ghrelin and GH secretion. Nippon Ronen Igakkai Zasshi 40 (2003) 341-343
127. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279 (2000) 909-913
128. Hosoda H., Kojima M., Mizushima T., Shimizu S., and Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J. Biol. Chem. 278 (2003) 64-70
129. Hou Z., Miao Y., Gao L., Pan H., and Zhu S. Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul. Pept. 134 (2006) 126-131
130. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., and Van der Ploeg L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
131. Hoybye C., Barkeling B., Espelund U., Petersson M., and Thoren M. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. Growth Horm. IGF Res. 13 (2003) 322-327
132. Iwase M., Kanazawa H., Kato Y., Nishizawa T., Somura F., Ishiki R., Nagata K., Hashimoto K., Takagi K., Izawa H., and Yokota M. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. Cardiovasc. Res. 61 (2004) 30-38
133. Janssen J.A., van der Toorn F.M., Hofland L.J., van Koetsveld P., Broglio F., Ghigo E., Lamberts S.W., and Jan van der Lely A. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur. J. Endocrinol. 145 (2001) 711-716
134. Jeffery P.L., Herington A.C., and Chopin L.K. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J. Endocrinol. 172 (2002) R7-R11
135. Jeffery P.L., Herington A.C., and Chopin L.K. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev. 14 (2003) 113-122
136. Jeffery P.L., Murray R.E., Yeh A.H., McNamara J.F., Duncan R.P., Francis G.D., Herington A.C., and Chopin L.K. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr. Relat. Cancer 12 (2005) 839-850
137. Jia Y.D., Chen X., Tang M., and Jiang Z.Y. Expression of growth hormone secretagogue receptor type 1a in visceral vagal and spinal afferent parthways. Sheng Li Xue Bao 60 (2008) 149-155
138. Kageyama H., Kitamura Y., Hosono T., Kintaka Y., Seki M., Takenoya F., Hori Y., Nonaka N., Arata S., and Shioda S. Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice. Regul. Pept. 145 (2008) 116-121
139. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., and Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141 (2000) 4797-4800
140. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., and Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 50 (2001) 2438-2443
141. Kanehisa M., Akiyoshi J., Kitaichi T., Matsushita H., Tanaka E., Kodama K., Hanada H., and Isogawa K. Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1403-1407
142. Kempa A., Krzyzanowska-Swiniarska B., Miazgowski T., and Pilarska K. Not insulin but insulin sensitivity, leptin, and cortisol are major factors regulating serum acylated ghrelin level in healthy women. J. Endocrinol. Invest. 30 (2007) 659-665
143. Kim M.S., Yoon C.Y., Jang P.G., Park Y.J., Shin C.S., Park H.S., Ryu J.W., Pak Y.K., Park J.Y., Lee K.U., Kim S.Y., Lee H.K., Kim Y.B., and Park K.S. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol. Endocrinol. 18 (2004) 2291-2301
144. Kineman R.D., Gahete M.D., and Luque R.M. Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. J. Mol. Endocrinol. 38 (2007) 511-521
145. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., Schurmann A., Joost H.G., Jandacek R.J., Hale J.E., Heiman M.L., and Tschop M.H. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med. 15 (2009) 741-745
146. Kitazawa T., De Smet B., Verbeke K., Depoortere I., and Peeters T.L. Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 54 (2005) 1078-1084
147. Kohno D., Gao H.Z., Muroya S., Kikuyama S., and Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52 (2003) 948-956
148. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiol. Rev. 85 (2005) 495-522
149. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
150. Kokkinos A., Mourouzis I., Kyriaki D., Pantos C., Katsilambros N., and Cokkinos D.V. Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocrine 32 (2007) 30-32
151. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G., Kangawa K., and Grossman A.B. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 86 (2001) 881-887
152. Korbonits M., Kojima M., Kangawa K., and Grossman A.B. Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 14 (2001) 101-104
153. Korbonits M., Gueorguiev M., O'Grady E., Lecoeur C., Swan D.C., Mein C.A., Weill J., Grossman A.B., and Froguel P. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J. Clin. Endocrinol. Metab. 87 (2002) 4005-4008
154. Krude H., Biebermann H., Luck W., Horn R., Brabant G., and Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19 (1998) 155-157
155. Lasseter K.C., Shaughnessy L., Cummings D., Pezzullo J.C., Wargin W., Gagnon R., Oliva J., and Kosutic G. Ghrelin Agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J. Clin. Pharmacol. 48 (2008) 193-202
156. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem. Biophys. Res. Commun. 351 (2006) 21-25
157. Lee Y.S., Challis B.G., Thompson D.A., Yeo G.S., Keogh J.M., Madonna M.E., Wraight V., Sims M., Vatin V., Meyre D., Shield J., Burren C., Ibrahim Z., Cheetham T., Swift P., Blackwood A., Hung C.C., Wareham N.J., Froguel P., Millhauser G.L., O'Rahilly S., and Farooqi I.S. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3 (2006) 135-140
158. Leonetti F., Silecchia G., Iacobellis G., Ribaudo M.C., Zappaterreno A., Tiberti C., Iannucci C.V., Perrotta N., Bacci V., Basso M.S., Basso N., and Di Mario U. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4227-4231
159. Leung P.K., Chow K.B., Lau P.N., Chu K.M., Chan C.B., Cheng C.H., and Wise H. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell. Signal. 19 (2007) 1011-1022
160. Levin F., Edholm T., Schmidt P.T., Gryback P., Jacobsson H., Degerblad M., Hoybye C., Holst J.J., Rehfeld J.F., Hellstrom P.M., and Naslund E. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J. Clin. Endocrinol. Metab. 91 (2006) 3296-3302
161. Li L., Zhang L.K., Pang Y.Z., Pan C.S., Qi Y.F., Chen L., Wang X., Tang C.S., and Zhang J. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol. Sin. 27 (2006) 527-535
162. Liu Y.L., Yakar S., Otero-Corchon V., Low M.J., and Liu J.L. Ghrelin gene expression is age-dependent and influenced by gender and the level of circulating IGF-I. Mol. Cell. Endocrinol. 189 (2002) 97-103
163. Liu J., Prudom C.E., Nass R., Pezzoli S.S., Oliveri M.C., Johnson M.L., Veldhuis P., Gordon D.A., Howard A.D., Witcher D.R., Geysen H.M., Gaylinn B.D., and Thorner M.O. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J. Clin. Endocrinol. Metab. 93 (2008) 1980-1987
164. Locatelli V., Rossoni G., Schweiger F., Torsello A., De Gennaro Colonna V., Bernareggi M., Deghenghi R., Muller E.E., and Berti F. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology 140 (1999) 4024-4031
165. Longo K.A., Charoenthongtrakul S., Giuliana D.J., Govek E.K., McDonagh T., Qi Y., Distefano P.S., and Geddes B.J. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regul. Pept. (2008)
166. Lopez M., Lage R., Saha A.K., Perez-Tilve D., Vazquez M.J., Varela L., Sangiao-Alvarellos S., Tovar S., Raghay K., Rodriguez-Cuenca S., Deoliveira R.M., Castaneda T., Datta R., Dong J.Z., Culler M., Sleeman M.W., Alvarez C.V., Gallego R., Lelliott C.J., Carling D., Tschop M.H., Dieguez C., and Vidal-Puig A. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 7 (2008) 389-399
167. Lu S., Guan J.L., Wang Q.P., Uehara K., Yamada S., Goto N., Date Y., Nakazato M., Kojima M., Kangawa K., and Shioda S. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci. Lett. 321 (2002) 157-160
168. Lucidi P., Murdolo G., Di Loreto C., De Cicco A., Parlanti N., Fanelli C., Santeusanio F., Bolli G.B., and De Feo P. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes 51 (2002) 2911-2914
169. Lucidi P., Murdolo G., Di Loreto C., Parlanti N., De Cicco A., Fatone C., Taglioni C., Fanelli C., Broglio F., Ghigo E., Bolli G.B., Santeusanio F., and De Feo P. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations. Nutr. Metab. Cardiovasc. Dis. 15 (2005) 410-417
170. Lund L.H., Williams J.J., Freda P., Lamanca J.J., Lejemtel T.H., and Mancini D.M. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur. J. Heart Fail. 11 (2009) 789-794
171. Luquet S., Perez F.A., Hnasko T.S., and Palmiter R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310 (2005) 683-685
172. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., Birnbaum S., Yanagisawa M., Elmquist J.K., Nestler E.J., and Zigman J.M. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. (2008)
173. Madeddu C., and Mantovani G. An update on promising agents for the treatment of cancer cachexia. Curr. Opin. Support. Palliat. Care (2009)
174. Malik S., McGlone F., Bedrossian D., and Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 7 (2008) 400-409
175. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., Hosoda H., Kojima M., and Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun. 276 (2000) 905-908
176. Matta S.G., Valentine J.D., and Sharp B.M. Nicotine activates NPY and catecholaminergic neurons in brainstem regions involved in ACTH secretion. Brain Res. 759 (1997) 259-269
177. Mayorov A.V., Amara N., Chang J.Y., Moss J.A., Hixon M.S., Ruiz D.I., Meijler M.M., Zorrilla E.P., and Janda K.D. Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice. Proc. Natl. Acad. Sci. USA (2008)
178. McKee K.K., Palyha O.C., Feighner S.D., Hreniuk D.L., Tan C.P., Phillips M.S., Smith R.G., Van der Ploeg L.H., and Howard A.D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol. Endocrinol. 11 (1997) 415-423
179. Miljic D., Pekic S., Djurovic M., Doknic M., Milic N., Casanueva F.F., Ghatei M., and Popovic V. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 91 (2006) 1491-1495
180. Mokdad A.H., Marks J.S., Stroup D.F., and Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 291 (2004) 1238-1245
181. Momany F.A., Bowers C.Y., Reynolds G.A., Chang D., Hong A., and Newlander K. Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology 108 (1981) 31-39
182. Mondal M.S., Date Y., Yamaguchi H., Toshinai K., Tsuruta T., Kangawa K., and Nakazato M. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul. Pept. 126 (2005) 55-59
183. Mori K., Yoshimoto A., Takaya K., Hosoda K., Ariyasu H., Yahata K., Mukoyama M., Sugawara A., Hosoda H., Kojima M., Kangawa K., and Nakao K. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett. 486 (2000) 213-216
184. Morley J.E. Anorexia of aging: physiologic and pathologic. Am. J. Clin. Nutr. 66 (1997) 760-773
185. Moulin A., Demange L., Berge G., Gagne D., Ryan J., Mousseaux D., Heitz A., Perrissoud D., Locatelli V., Torsello A., Galleyrand J.C., Fehrentz J.A., and Martinez J. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. J. Med. Chem. 50 (2007) 5790-5806
186. Moulin A., Demange L., Ryan J., Mousseaux D., Sanchez P., Berge G., Gagne D., Perrissoud D., Locatelli V., Torsello A., Galleyrand J.C., Fehrentz J.A., and Martinez J. New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations. J. Med. Chem. 51 (2008) 689-693
187. Muccioli G., Tschop M., Papotti M., Deghenghi R., Heiman M., and Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 440 (2002) 235-254
188. Muccioli G., Pons N., Ghe C., Catapano F., Granata R., and Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur. J. Pharmacol. 498 (2004) 27-35
189. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., Kojima M., Kangawa K., and Chihara K. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 277 (2002) 5667-5674
190. Murdoch D.R., and McMurray J.J. Cardiac cachexia - lean and mean. Eur. Heart J. 20 (1999) 1609-1611
191. Murdolo G., Lucidi P., Di Loreto C., Parlanti N., De Cicco A., Fanelli C., Perriello G., Mughetti D., Pippi R., Brozzetti A., Santeusanio F., and De Feo P. Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. J. Endocrinol. Invest. 26 (2003) 244-249
192. Murphy M.G., Bach M.A., Plotkin D., Bolognese J., Ng J., Krupa D., Cerchio K., and Gertz B.J. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 study group. J. Bone Miner. Res. 14 (1999) 1182-1188
193. Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., Johnston C., Bloom S.R., and Emmanuel A.V. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54 (2005) 1693-1698
194. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Hayashi Y., and Kangawa K. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1483-R1487
195. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., and Kangawa K. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104 (2001) 2034-2038
196. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., and Kangawa K. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 (2001) 1430-1435
197. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., Ueno K., Kitakaze M., Miyatake K., and Kangawa K. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110 (2004) 3674-3679
198. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
199. Nanzer A.M., Khalaf S., Mozid A.M., Fowkes R.C., Patel M.V., Burrin J.M., Grossman A.B., and Korbonits M. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur. J. Endocrinol. 151 (2004) 233-240
200. Nass R., Farhy L.S., Liu J., Prudom C.E., Johnson M.L., Veldhuis P., Pezzoli S.S., Oliveri M.C., Gaylinn B.D., Geysen H.M., and Thorner M.O. Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. J. Clin. Endocrinol. Metab. 93 (2008) 1988-1994
201. Nass R., Pezzoli S.S., Oliveri M.C., Patrie J.T., Harrell Jr. F.E., Clasey J.L., Heymsfield S.B., Bach M.A., Vance M.L., and Thorner M.O. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann. Intern. Med. 149 (2008) 601-611
202. Neary N.M., Small C.J., Wren A.M., Lee J.L., Druce M.R., Palmieri C., Frost G.S., Ghatei M.A., Coombes R.C., and Bloom S.R. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89 (2004) 2832-2836
203. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., Perez-Tilve D., Vazquez M.J., Wiedmer P., Castaneda T.R., DiMarchi R., Tschop M., Schurmann A., Joost H.G., Williams L.M., Langhans W., and Dieguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148 (2007) 21-26
204. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., Pfluger P.T., Castaneda T.R., Neschen S., Hofmann S.M., Howles P.N., Morgan D.A., Benoit S.C., Szanto I., Schrott B., Schurmann A., Joost H.G., Hammond C., Hui D.Y., Woods S.C., Rahmouni K., Butler A.A., Farooqi I.S., O'Rahilly S., Rohner-Jeanrenaud F., and Tschop M.H. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117 (2007) 3475-3488
205. Norrelund H., Hansen T.K., Orskov H., Hosoda H., Kojima M., Kangawa K., Weeke J., Moller N., Christiansen J.S., and Jorgensen J.O. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin. Endocrinol. (Oxford) 57 (2002) 539-546
206. Ohliger-Frerking P., Horowitz J.M., and Horwitz B.A. Enhanced adrenergic excitation of serotonergic dorsal raphe neurons in genetically obese rats. Neurosci. Lett. 332 (2002) 107-110
207. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., Heiman M.L., Lehnert P., Fichter M., and Tschop M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145 (2001) 669-673
208. Owens D.R., Zinman B., and Bolli G.B. Insulins today and beyond. Lancet 358 (2001) 739-746
209. Pantel J., Legendre M., Cabrol S., Hilal L., Hajaji Y., Morisset S., Nivot S., Vie-Luton M.P., Grouselle D., de Kerdanet M., Kadiri A., Epelbaum J., Le Bouc Y., and Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest. 116 (2006) 760-768
210. Patel A.D., Stanley S.A., Murphy K.G., Frost G.S., Gardiner J.V., Kent A.S., White N.E., Ghatei M.A., and Bloom S.R. Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul. Pept. 134 (2006) 17-22
211. Patterson M., Murphy K.G., le Roux C.W., Ghatei M.A., and Bloom S.R. Characterization of ghrelin-like immunoreactivity in human plasma. J. Clin. Endocrinol. Metab. 90 (2005) 2205-2211
212. Peeters T.L. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders. Curr. Opin. Pharmacol. 6 (2006) 553-558
213. Pfluger P.T., Kirchner H., Gunnel S., Schrott B., Perez-Tilve D., Fu S., Benoit S.C., Horvath T., Joost H.G., Wortley K.E., Sleeman M.W., and Tschop M.H. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am. J. Physiol. Gastrointest. Liver Physiol. (2007)
214. Poitras P., Polvino W.J., and Rocheleau B. Gastrokinetic effect of ghrelin analog RC-1139 in the rat. Effect on post-operative and on morphine induced ileus. Peptides 26 (2005) 1598-1601
215. Pomes A., Pong S.S., and Schaeffer J.M. Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes. Biochem. Biophys. Res. Commun. 225 (1996) 939-945
216. Popovic V., Miljic D., Micic D., Damjanovic S., Arvat E., Ghigo E., Dieguez C., and Casanueva F.F. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J. Clin. Endocrinol. Metab. 88 (2003) 3450-3453
217. Prado C.L., Pugh-Bernard A.E., Elghazi L., Sosa-Pineda B., and Sussel L. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci. USA 101 (2004) 2924-2929
218. Purnell J.Q., Cummings D., and Weigle D.S. Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with loss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity. Int. J. Obes. (London) 31 (2007) 385-389
219. Qi X., Reed J., Englander E.W., Chandrashekar V., Bartke A., and Greeley Jr. G.H. Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. Exp. Biol. Med. (Maywood) 228 (2003) 1028-1032
220. Qi X., Reed J.T., Wang G., Han S., Englander E.W., and Greeley Jr. G.H. Ghrelin secretion is not reduced by increased fat mass during diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2008)
221. Rauh M., Groschl M., and Rascher W. Simultaneous quantification of ghrelin and desacyl-ghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell supernatants. Clin. Chem. 53 (2007) 902-910
222. Reimer M.K., Pacini G., and Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144 (2003) 916-921
223. Reinehr T., de Sousa G., and Roth C.L. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin. Endocrinol. (Oxford) (2007)
224. Rigamonti A.E., Pincelli A.I., Corra B., Viarengo R., Bonomo S.M., Galimberti D., Scacchi M., Scarpini E., Cavagnini F., and Muller E.E. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J. Endocrinol. 175 (2002) R1-R5
225. Rudolph J., Esler W.P., O'Connor S., Coish P.D., Wickens P.L., Brands M., Bierer D.E., Bloomquist B.T., Bondar G., Chen L., Chuang C.Y., Claus T.H., Fathi Z., Fu W., Khire U.R., Kristie J.A., Liu X.G., Lowe D.B., McClure A.C., Michels M., Ortiz A.A., Ramsden P.D., Schoenleber R.W., Shelekhin T.E., Vakalopoulos A., Tang W., Wang L., Yi L., Gardell S.J., Livingston J.N., Sweet L.J., and Bullock W.H. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. J. Med. Chem. 50 (2007) 5202-5216
226. Saad M.F., Bernaba B., Hwu C.M., Jinagouda S., Fahmi S., Kogosov E., and Boyadjian R. Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab. 87 (2002) 3997-4000
227. Sakata I., Nakamura K., Yamazaki M., Matsubara M., Hayashi Y., Kangawa K., and Sakai T. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 23 (2002) 531-536
228. Sakata I., Yang J., Lee C.E., Osborne-Lawrence S., Rovinsky S.A., Elmquist J.K., and Zigman J.M. Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. Am. J. Physiol. Endocrinol. Metab. 297 (2009) E134-E141
229. Salehi A., Dornonville de la Cour C., Hakanson R., and Lundquist I. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul. Pept. 118 (2004) 143-150
230. Salome N., Haage D., Perrissoud D., Moulin A., Demange L., Egecioglu E., Fehrentz J.A., Martinez J., and Dickson S.L. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats. Eur. J. Pharmacol. 612 (2009) 167-173
231. Sato T., Fukue Y., Teranishi H., Yoshida Y., and Kojima M. Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology 146 (2005) 2510-2516
232. Sato M., Nakahara K., Goto S., Kaiya H., Miyazato M., Date Y., Nakazato M., Kangawa K., and Murakami N. Effects of ghrelin and des-acyl ghrelin on neurogenesis of the rat fetal spinal cord. Biochem. Biophys. Res. Commun. 350 (2006) 598-603
233. Savage D.B., Agostini M., Barroso I., Gurnell M., Luan J., Meirhaeghe A., Harding A.H., Ihrke G., Rajanayagam O., Soos M.A., George S., Berger D., Thomas E.L., Bell J.D., Meeran K., Ross R.J., Vidal-Puig A., Wareham N.J., O'Rahilly S., Chatterjee V.K., and Schafer A.J. Digenic inheritance of severe insulin resistance in a human pedigree. Nat. Genet. 31 (2002) 379-384
234. Schaller G., Schmidt A., Pleiner J., Woloszczuk W., Wolzt M., and Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 52 (2003) 16-20
235. Seoane L.M., Tovar S., Baldelli R., Arvat E., Ghigo E., Casanueva F.F., and Dieguez C. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur. J. Endocrinol. 143 (2000) R7-R9
236. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., Nozoe S., Hosoda H., Kangawa K., and Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87 (2002) 240-244
237. Shimizu Y., Nagaya N., Isobe T., Imazu M., Okumura H., Hosoda H., Kojima M., Kangawa K., and Kohno N. Increased plasma ghrelin level in lung cancer cachexia. Clin. Cancer Res. 9 (2003) 774-778
238. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., and Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 (2001) 227-232
239. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., Kamegai J., Sugihara H., Oikawa S., and Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J. Clin. Invest. 109 (2002) 1429-1436
240. Smith R.G., Palyha O.C., Feighner S.D., Tan C.P., McKee K.K., Hreniuk D.L., Yang L., Morriello G., Nargund R., Patchett A.A., and Howard A.D. Growth hormone releasing substances: types and their receptors. Horm. Res. 51 Suppl 3 (1999) 1-8
241. Smith R.G., Sun Y., Jiang H., Albarran-Zeckler R., and Timchenko N. Ghrelin Receptor (GHS-R1A) Agonists show potential as interventive agents during aging. Ann. NY Acad. Sci. 1119 (2007) 147-164
242. Strassburg S., Anker S., Castaneda T., Burget L., Perez-Tilve D., Pfluger P.T., Nogueiras R., Halem H., Dong J.Z., Culler M., Datta R., and Tschop M.H. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. Endocrinol. Metab. (2008)
243. Sturm K., MacIntosh C.G., Parker B.A., Wishart J., Horowitz M., and Chapman I.M. Appetite, food intake, and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women. J. Clin. Endocrinol. Metab. 88 (2003) 3747-3755
244. Sugimoto T., Nakaoka D., Nasu M., Kanzawa M., Sugishita T., and Chihara K. Effect of recombinant human growth hormone in elderly osteoporotic women. Clin. Endocrinol. (Oxford) 51 (1999) 715-724
245. Sun Y., Wang P., Zheng H., and Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 101 (2004) 4679-4684
246. Sun Y., Asnicar M., Saha P.K., Chan L., and Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 3 (2006) 379-386
247. Sun Y., Butte N.F., Garcia J.M., and Smith R.G. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology (2007)
248. Tack J., Depoortere I., Bisschops R., Verbeke K., Janssens J., and Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment. Pharmacol. Ther. 22 (2005) 847-853
249. Tack J., Depoortere I., Bisschops R., Delporte C., Coulie B., Meulemans A., Janssens J., and Peeters T. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55 (2006) 327-333
250. Tacke F., Brabant G., Kruck E., Horn R., Schoffski P., Hecker H., Manns M.P., and Trautwein C. Ghrelin in chronic liver disease. J. Hepatol. 38 (2003) 447-454
251. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., Shimatsu A., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., and Nakao K. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 85 (2000) 4908-4911
252. Takeno R., Okimura Y., Iguchi G., Kishimoto M., Kudo T., Takahashi K., Takahashi Y., Kaji H., Ohno M., Ikuta H., Kuroda Y., Obara T., Hosoda H., Kangawa K., and Chihara K. Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. Eur. J. Endocrinol. 151 (2004) 447-450
253. Tamura H., Kamegai J., Shimizu T., Ishii S., Sugihara H., and Oikawa S. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 143 (2002) 3268-3275
254. Tena-Sempere M., Barreiro M.L., Gonzalez L.C., Gaytan F., Zhang F.P., Caminos J.E., Pinilla L., Casanueva F.F., Dieguez C., and Aguilar E. Novel expression and functional role of ghrelin in rat testis. Endocrinology 143 (2002) 717-725
255. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., Castaneda T.R., Muzzin P., Schurmann A., Szanto I., Tschop M.H., and Rohner-Jeanrenaud F. Ghrelin action in the brain controls adipocyte metabolism. J. Clin. Invest. 116 (2006) 1983-1993
256. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., and Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 (2004) 234-242
257. Tolle V., Bassant M.H., Zizzari P., Poindessous-Jazat F., Tomasetto C., Epelbaum J., and Bluet-Pajot M.T. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143 (2002) 1353-1361
258. Tomasetto C., Karam S.M., Ribieras S., Masson R., Lefebvre O., Staub A., Alexander G., Chenard M.P., and Rio M.C. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119 (2000) 395-405
259. Torsello A., Bresciani E., Rossoni G., Avallone R., Tulipano G., Cocchi D., Bulgarelli I., Deghenghi R., Berti F., and Locatelli V. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology 144 (2003) 1787-1792
260. Toshinai K., Mondal M.S., Nakazato M., Date Y., Murakami N., Kojima M., Kangawa K., and Matsukura S. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun. 281 (2001) 1220-1225
261. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.L., Wang Q.P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., and Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144 (2003) 1506-1512
262. Toth K., Laszlo K., Lukacs E., and Lenard L. Intraamygdaloid microinjection of acylated-ghrelin influences passive avoidance learning. Behav. Brain Res. 202 (2009) 308-311
263. Trudel L., Tomasetto C., Rio M.C., Bouin M., Plourde V., Eberling P., and Poitras P. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G948-G952
264. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
265. Tschop M., Wawarta R., Riepl R.L., Friedrich S., Bidlingmaier M., Landgraf R., and Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24 (2001) RC19-RC21
266. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
267. Tschop M., Statnick M.A., Suter T.M., and Heiman M.L. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology 143 (2002) 558-568
268. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., and Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308 (2005) 1043-1045
269. Ueberberg B., Unger N., Saeger W., Mann K., and Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm. Metab. Res. (2009)
270. Ukkola O., Ravussin E., Jacobson P., Snyder E.E., Chagnon M., Sjostrom L., and Bouchard C. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J. Clin. Endocrinol. Metab. 86 (2001) 3996-3999
271. Ukkola O., Ravussin E., Jacobson P., Perusse L., Rankinen T., Tschop M., Heiman M.L., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Sjostrom L., and Bouchard C. Role of ghrelin polymorphisms in obesity based on three different studies. Obes. Res. 10 (2002) 782-791
272. Vaisse C., Clement K., Durand E., Hercberg S., Guy-Grand B., and Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106 (2000) 253-262
273. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25 (2004) 426-457
274. Vanhorebeek I., and Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr. Opin. Pharmacol. 4 (2004) 621-628
275. Venkova K., Fraser G., Hoveyda H.R., and Greenwood-Van Meerveld B. Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus. Dig. Dis. Sci. 52 (2007) 2241-2248
276. Vestergaard E.T., Hansen T.K., Nielsen S., Moller N., Christiansen J.S., and Jorgensen J.O. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. Eur. J. Endocrinol. 153 (2005) 545-549
277. Vestergaard E.T., Djurhuus C.B., Gjedsted J., Nielsen S., Moller N., Holst J.J., Jorgensen J.O., and Schmitz O. Acute effects of ghrelin administration on glucose and lipid metabolism. J. Clin. Endocrinol. Metab. (2007)
278. Vestergaard E.T., Hansen T.K., Gormsen L.C., Jakobsen P., Moller N., Christiansen J.S., and Jorgensen J.O. Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1829-E1836
279. Vicennati V., Genghini S., De Iasio R., Pasqui F., Pagotto U., and Pasquali R. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur. J. Endocrinol. 157 (2007) 295-301
280. Vittal H., Farrugia G., Gomez G., and Pasricha P.J. Mechanisms of disease: the pathological basis of gastroparesis - a review of experimental and clinical studies. Nat. Clin. Pract. Gastroenterol. Hepatol. 4 (2007) 336-346
281. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Deghenghi R., Muccioli G., Ghigo E., and Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 87 (2002) 1300-1308
282. Volante M., Fulcheri E., Allia E., Cerrato M., Pucci A., and Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J. Histochem. Cytochem. 50 (2002) 1013-1021
283. Volante M., Allia E., Fulcheri E., Cassoni P., Ghigo E., Muccioli G., and Papotti M. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am. J. Pathol. 162 (2003) 645-654
284. Wang H.J., Geller F., Dempfle A., Schauble N., Friedel S., Lichtner P., Fontenla-Horro F., Wudy S., Hagemann S., Gortner L., Huse K., Remschmidt H., Bettecken T., Meitinger T., Schafer H., Hebebrand J., and Hinney A. Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J. Clin. Endocrinol. Metab. 89 (2004) 157-162
285. Wang Y., Dong L., Cheng Y., and Zhao P. Effects of ghrelin on feeding regulation and interdigestive migrating complex in rats. Scand. J. Gastroenterol. 42 (2007) 447-453
286. Wang D.H., Hu Y.S., Du J.J., Hu Y.Y., Zhong W.D., and Qin W.J. Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway. Endocrine (2008)
287. Wei W., Qi X., Reed J., Ceci J., Wang H.Q., Wang G., Englander E.W., and Greeley Jr. G.H. Effect of chronic hyperghrelinemia on ingestive action of ghrelin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R803-R808
288. Weikel J.C., Wichniak A., Ising M., Brunner H., Friess E., Held K., Mathias S., Schmid D.A., Uhr M., and Steiger A. Ghrelin promotes slow-wave sleep in humans. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E407-E415
289. White H.K., Petrie C.D., Landschulz W., MacLean D., Taylor A., Lyles K., Wei J.Y., Hoffman A.R., Salvatori R., Ettinger M.P., Morey M.C., Blackman M.R., and Merriam G.R. Effects of an oral growth hormone secretagogue in older adults. J. Clin. Endocrinol. Metab. 94 (2009) 1198-1206
290. Wickelgren I. Obesity: how big a problem?. Science 280 (1998) 1364-1367
291. Wierup N., Svensson H., Mulder H., and Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul. Pept. 107 (2002) 63-69
292. Wierup N., Yang S., McEvilly R.J., Mulder H., and Sundler F. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J. Histochem. Cytochem. 52 (2004) 301-310
293. Willesen M.G., Kristensen P., and Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70 (1999) 306-316
294. Williams D.L., Cummings D.E., Grill H.J., and Kaplan J.M. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 144 (2003) 2765-2767
295. Wortley K.E., del Rincon J.P., Murray J.D., Garcia K., Iida K., Thorner M.O., and Sleeman M.W. Absence of ghrelin protects against early-onset obesity. J. Clin. Invest. 115 (2005) 3573-3578
296. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., and Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86 (2001) 5992
297. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., and Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 (2001) 2540-2547
298. Wurtman J.J., Lieberman H., Tsay R., Nader T., and Chew B. Calorie and nutrient intakes of elderly and young subjects measured under identical conditions. J. Gerontol. 43 (1988) B174-B180
299. Xu L., Depoortere I., Tomasetto C., Zandecki M., Tang M., Timmermans J.P., and Peeters T.L. Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul. Pept. 124 (2005) 119-125
300. Xu X., Pang J., Yin H., Li M., Hao W., Chen C., and Cao J.M. Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H2952-H2958
301. Xu X., Jhun B.S., Ha C.H., and Jin Z.G. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology (2008)
302. Yang J., Brown M.S., Liang G., Grishin N.V., and Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 (2008) 387-396
303. Yoshimoto A., Mori K., Sugawara A., Mukoyama M., Yahata K., Suganami T., Takaya K., Hosoda H., Kojima M., Kangawa K., and Nakao K. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J. Am. Soc. Nephrol. 13 (2002) 2748-2752
304. Zhang W., Zhao L., Lin T.R., Chai B., Fan Y., Gantz I., and Mulholland M.W. Inhibition of adipogenesis by ghrelin. Mol. Biol. Cell 15 (2004) 2484-2491
305. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., and Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
306. Zigman J.M., and Elmquist J.K. Minireview: from anorexia to obesity - the yin and yang of body weight control. Endocrinology 144 (2003) 3749-3756
307. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., Seeley R.J., Lowell B.B., and Elmquist J.K. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 115 (2005) 3564-3572
308. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., and Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 494 (2006) 528-548
309. Zizzari P., Halem H., Taylor J., Dong J.Z., Datta R., Culler M.D., Epelbaum J., and Bluet-Pajot M.T. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 146 (2005) 3836-3842
310. Zizzari P., Longchamps R., Epelbaum J., and Bluet-Pajot M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148 (2007) 1648-1653
311. Zorrilla E.P., Iwasaki S., Moss J.A., Chang J., Otsuji J., Inoue K., Meijler M.M., and Janda K.D. Vaccination against weight gain. Proc. Natl. Acad. Sci. USA 103 (2006) 13226-13231
312. Zwirska-Korczala K., Adamczyk-Sowa M., Sowa P., Pilc K., Suchanek R., Pierzchala K., Namyslowski G., Misiolek M., Sodowski K., Kato I., Kuwahara A., and Zabielski R. Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. J. Physiol. Pharmacol. 58 Suppl. 1 (2007) 53-64